Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 247

Similar articles for PubMed (Select 8276370)

1.

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.

Angeli P, Dalla Pria M, De Bei E, Albino G, Caregaro L, Merkel C, Ceolotto G, Gatta A.

Hepatology. 1994 Jan;19(1):72-9.

PMID:
8276370
2.
3.

Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.

Angeli P, Fasolato S, Mazza E, Okolicsanyi L, Maresio G, Velo E, Galioto A, Salinas F, D'Aquino M, Sticca A, Gatta A.

Gut. 2010 Jan;59(1):98-104. doi: 10.1136/gut.2008.176495. Epub .

PMID:
19570764
4.

Stepped care medical treatment for cirrhotic ascites: analysis of factors influencing the response to treatment.

Takaya A, Fukui H, Matsumura M, Uemura M, Kojima H, Okamoto S, Tsujii T.

J Gastroenterol Hepatol. 1995 Jan-Feb;10(1):30-5.

PMID:
7620104
5.
6.
7.

Effects of amiloride on renal lithium handling in nonazotemic ascitic cirrhotic patients with avid sodium retention.

Angeli P, De Bei E, Dalla Pria M, Caregaro L, Ceolotto G, Albino G, Gatta A.

Hepatology. 1992 Apr;15(4):651-4.

PMID:
1551643
8.

The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.

Kalambokis G, Economou M, Kosta P, Papadimitriou K, Tsianos EV.

J Clin Gastroenterol. 2006 Apr;40(4):342-6.

PMID:
16633107
9.

[Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].

Traina M, Vizzini GB.

Minerva Med. 1986 Jan 28;77(3-4):87-91. Italian.

PMID:
3511409
10.

Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.

Laffi G, Marra F, Buzzelli G, Azzena G, Meacci E, De Feo ML, La Villa G, Gentilini P.

Hepatology. 1991 Jun;13(6):1101-5.

PMID:
2050329
11.

Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content.

Bernardi M, Laffi G, Salvagnini M, Azzena G, Bonato S, Marra F, Trevisani F, Gasbarrini G, Naccarato R, Gentilini P.

Liver. 1993 Jun;13(3):156-62.

PMID:
8336527
12.

Antihypertensive effect of captopril, canrenoate potassium, and atenolol. Relations with red blood cell sodium transport and renin.

Niutta E, Cusi D, Colombo R, Tripodi G, Pellizzoni M, Pati P, Cesana B, Alberghini E, Barlassina C, Bianchi G.

Am J Hypertens. 1988 Oct;1(4 Pt 1):364-71.

PMID:
3063286
13.

Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. A prospective, controlled, randomized trial.

Sarin SK, Sachdev G, Mishra SP, Sundaram KR, Shrivastwa A, Talukdar V, Broor SL.

Digestion. 1988;41(2):101-7.

PMID:
3065101
14.

Torasemide in the treatment of patients with cirrhosis and ascites.

Gentilini P, Laffi G, La Villa G, Carloni V, Foschi M, Romanelli RG, Marra F.

Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:81-5.

PMID:
8435382
15.

Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.

Andriulli A, Arrigoni A, Gindro T, Karbowiak I, Buzzetti G, Armanini D.

Digestion. 1989;44(3):155-62.

PMID:
2697627
16.

Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.

Yang YY, Lin HC, Lin MW, Chu CJ, Lee FY, Hou MC, Lee SD, Lee WP, Liu TT, Jap TS.

Clin Sci (Lond). 2011 Dec;121(11):509-21. doi: 10.1042/CS20110018.

PMID:
21692745
17.

Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.

Fernández-Esparrach G, Guevara M, Sort P, Pardo A, Jiménez W, Ginès P, Planas R, Lebrec D, Geuvel A, Elewaut A, Adler M, Arroyo V.

J Hepatol. 1997 Mar;26(3):614-20. Erratum in: J Hepatol 1997 Jun;26(6):1430.

PMID:
9075669
18.

Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.

Ljubicić N, Kujundzić M, Banić M, Vrkljan M.

Scand J Gastroenterol. 1998 Apr;33(4):441-7.

PMID:
9605268
20.

Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.

Emili M, Cuppone R, Ricci GL.

Arzneimittelforschung. 1988 Oct;38(10):1492-5.

PMID:
3058132
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk